Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex.
Celiac disease and multiple sclerosis in the northwest of Iran.
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
Validity and reliability of VO2-max measurements in persons with multiple sclerosis.
Reproductive issues in women with multiple sclerosis: ethical considerations.
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
ATX-MS-1467 - Positive Immunological data in Multiple Sclerosis: Final Phase I/IIa data shows safety and tolerability, plus efficacy
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation.
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
FDA approves Ampyra to improve walking in adults with multiple sclerosis
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis.
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.
Concurrent saturation transfer contrast in in vivo brain by a uniform magnetization transfer MRI.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
Pages
« first
‹ previous
…
114
115
116
117
118
119
120
121
122
…
next ›
last »